Cargando…

Epstein-Barr nuclear antigen 1 induces expression of the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphoma

Epstein-Barr Virus (EBV) is a γ-herpesvirus that infects >90% of the human population. Although EBV persists in its latent form in healthy carriers, the virus is also associated with several human cancers. EBV is strongly associated with Burkitt lymphoma (BL), even though there is still no satisf...

Descripción completa

Detalles Bibliográficos
Autores principales: Onnis, A, Navari, M, Antonicelli, G, Morettini, F, Mannucci, S, De Falco, G, Vigorito, E, Leoncini, L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432484/
https://www.ncbi.nlm.nih.gov/pubmed/22941339
http://dx.doi.org/10.1038/bcj.2012.29
_version_ 1782242213152948224
author Onnis, A
Navari, M
Antonicelli, G
Morettini, F
Mannucci, S
De Falco, G
Vigorito, E
Leoncini, L
author_facet Onnis, A
Navari, M
Antonicelli, G
Morettini, F
Mannucci, S
De Falco, G
Vigorito, E
Leoncini, L
author_sort Onnis, A
collection PubMed
description Epstein-Barr Virus (EBV) is a γ-herpesvirus that infects >90% of the human population. Although EBV persists in its latent form in healthy carriers, the virus is also associated with several human cancers. EBV is strongly associated with Burkitt lymphoma (BL), even though there is still no satisfactory explanation of how EBV participates in BL pathogenesis. However, new insights into the interplay between viruses and microRNAs (miRNAs) have recently been proposed. In particular, it has been shown that B-cell differentiation in EBV-positive BL is impaired at the post-transcriptional level by altered expression of hsa-miR-127. Here, we show that the overexpression of hsa-miR-127 is due to the presence of the EBV-encoded nuclear antigen 1 (EBNA1) and give evidence of a novel mechanism of direct regulation of the human miRNA by this viral product. Finally, we show that the combinatorial expression of EBNA1 and hsa-miR-127 affects the expression of master B-cell regulators in human memory B cells, confirming the scenario previously observed in EBV-positive BL primary tumors and cell lines. A good understanding of these mechanisms will help to clarify the complex regulatory networks between host and pathogen, and favor the design of more specific treatments for EBV-associated malignancies.
format Online
Article
Text
id pubmed-3432484
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-34324842012-09-05 Epstein-Barr nuclear antigen 1 induces expression of the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphoma Onnis, A Navari, M Antonicelli, G Morettini, F Mannucci, S De Falco, G Vigorito, E Leoncini, L Blood Cancer J Original Article Epstein-Barr Virus (EBV) is a γ-herpesvirus that infects >90% of the human population. Although EBV persists in its latent form in healthy carriers, the virus is also associated with several human cancers. EBV is strongly associated with Burkitt lymphoma (BL), even though there is still no satisfactory explanation of how EBV participates in BL pathogenesis. However, new insights into the interplay between viruses and microRNAs (miRNAs) have recently been proposed. In particular, it has been shown that B-cell differentiation in EBV-positive BL is impaired at the post-transcriptional level by altered expression of hsa-miR-127. Here, we show that the overexpression of hsa-miR-127 is due to the presence of the EBV-encoded nuclear antigen 1 (EBNA1) and give evidence of a novel mechanism of direct regulation of the human miRNA by this viral product. Finally, we show that the combinatorial expression of EBNA1 and hsa-miR-127 affects the expression of master B-cell regulators in human memory B cells, confirming the scenario previously observed in EBV-positive BL primary tumors and cell lines. A good understanding of these mechanisms will help to clarify the complex regulatory networks between host and pathogen, and favor the design of more specific treatments for EBV-associated malignancies. Nature Publishing Group 2012-08 2012-08-31 /pmc/articles/PMC3432484/ /pubmed/22941339 http://dx.doi.org/10.1038/bcj.2012.29 Text en Copyright © 2012 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
spellingShingle Original Article
Onnis, A
Navari, M
Antonicelli, G
Morettini, F
Mannucci, S
De Falco, G
Vigorito, E
Leoncini, L
Epstein-Barr nuclear antigen 1 induces expression of the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphoma
title Epstein-Barr nuclear antigen 1 induces expression of the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphoma
title_full Epstein-Barr nuclear antigen 1 induces expression of the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphoma
title_fullStr Epstein-Barr nuclear antigen 1 induces expression of the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphoma
title_full_unstemmed Epstein-Barr nuclear antigen 1 induces expression of the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphoma
title_short Epstein-Barr nuclear antigen 1 induces expression of the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphoma
title_sort epstein-barr nuclear antigen 1 induces expression of the cellular microrna hsa-mir-127 and impairing b-cell differentiation in ebv-infected memory b cells. new insights into the pathogenesis of burkitt lymphoma
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432484/
https://www.ncbi.nlm.nih.gov/pubmed/22941339
http://dx.doi.org/10.1038/bcj.2012.29
work_keys_str_mv AT onnisa epsteinbarrnuclearantigen1inducesexpressionofthecellularmicrornahsamir127andimpairingbcelldifferentiationinebvinfectedmemorybcellsnewinsightsintothepathogenesisofburkittlymphoma
AT navarim epsteinbarrnuclearantigen1inducesexpressionofthecellularmicrornahsamir127andimpairingbcelldifferentiationinebvinfectedmemorybcellsnewinsightsintothepathogenesisofburkittlymphoma
AT antonicellig epsteinbarrnuclearantigen1inducesexpressionofthecellularmicrornahsamir127andimpairingbcelldifferentiationinebvinfectedmemorybcellsnewinsightsintothepathogenesisofburkittlymphoma
AT morettinif epsteinbarrnuclearantigen1inducesexpressionofthecellularmicrornahsamir127andimpairingbcelldifferentiationinebvinfectedmemorybcellsnewinsightsintothepathogenesisofburkittlymphoma
AT mannuccis epsteinbarrnuclearantigen1inducesexpressionofthecellularmicrornahsamir127andimpairingbcelldifferentiationinebvinfectedmemorybcellsnewinsightsintothepathogenesisofburkittlymphoma
AT defalcog epsteinbarrnuclearantigen1inducesexpressionofthecellularmicrornahsamir127andimpairingbcelldifferentiationinebvinfectedmemorybcellsnewinsightsintothepathogenesisofburkittlymphoma
AT vigoritoe epsteinbarrnuclearantigen1inducesexpressionofthecellularmicrornahsamir127andimpairingbcelldifferentiationinebvinfectedmemorybcellsnewinsightsintothepathogenesisofburkittlymphoma
AT leoncinil epsteinbarrnuclearantigen1inducesexpressionofthecellularmicrornahsamir127andimpairingbcelldifferentiationinebvinfectedmemorybcellsnewinsightsintothepathogenesisofburkittlymphoma